Salix Pharmaceuticals develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. SLXP’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market these products through the company’s gastroenterology specialty sales and marketing team. For more information, visit the company’s Web site: http://www.salix.com
Let us hear your thoughts below: